ES367284A1 - Storage-stable vitamin preparations - Google Patents

Storage-stable vitamin preparations

Info

Publication number
ES367284A1
ES367284A1 ES367284A ES367284A ES367284A1 ES 367284 A1 ES367284 A1 ES 367284A1 ES 367284 A ES367284 A ES 367284A ES 367284 A ES367284 A ES 367284A ES 367284 A1 ES367284 A1 ES 367284A1
Authority
ES
Spain
Prior art keywords
storage
vitamin preparations
stable vitamin
weight
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES367284A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
E Merck AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Merck AG filed Critical E Merck AG
Publication of ES367284A1 publication Critical patent/ES367284A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Storage stable solid vitamin compositions comprise 0.1-50 parts by weight of at least one of folic acid, pantothenyl alcohol, pantothenic acid and the salts of pantothenic acid intimately mixed with 99.9-50 parts by weight of galactomannans obtained from guar endosperm flour and/or carob bean flour.
ES367284A 1968-05-16 1968-05-16 Storage-stable vitamin preparations Expired ES367284A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681767499 DE1767499A1 (en) 1968-05-16 1968-05-16 Process for the production of durable vitamin preparations

Publications (1)

Publication Number Publication Date
ES367284A1 true ES367284A1 (en) 1971-04-01

Family

ID=5699379

Family Applications (1)

Application Number Title Priority Date Filing Date
ES367284A Expired ES367284A1 (en) 1968-05-16 1968-05-16 Storage-stable vitamin preparations

Country Status (12)

Country Link
AT (1) AT285811B (en)
BE (1) BE733145A (en)
BR (1) BR6908845D0 (en)
CH (1) CH522405A (en)
DE (1) DE1767499A1 (en)
DK (1) DK122007B (en)
ES (1) ES367284A1 (en)
FR (1) FR2008690A1 (en)
GB (1) GB1201014A (en)
IL (1) IL32096A0 (en)
NL (1) NL6907431A (en)
SE (1) SE357304B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3263932D1 (en) * 1981-11-28 1985-07-04 Boehringer Mannheim Gmbh Guar gum preparation forms for oral administration
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
DE4119306C2 (en) * 1991-06-12 1996-05-30 Wheli Inter Ag Organic raw materials, intermediate and end products for nutrition and for use for technical purposes that contain vital substances
ZA936724B (en) 1992-09-14 1995-08-14 Vesta Med Pty Ltd Compositions for the treatment and prophylaxis of metabolic disturbances in infants
ZA936723B (en) * 1992-09-14 1995-08-14 Vesta Med Pty Ltd Pharmaceutical preparations for lowering homocysteine levels
DE19705555A1 (en) * 1997-02-13 1998-08-20 Ulrich Dr Posanski Thioctic acid pharmaceutical preparations for oral use
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
DE60023125T2 (en) 1999-03-08 2006-06-22 University Of Manitoba, Winnipeg PYRIDOXAL ANALOGUE FOR THE TREATMENT OF DISORDERS RELEASED BY A VITAMIN B6 LACK
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
JP2003525303A (en) 2000-02-29 2003-08-26 メディキュア インターナショナル インコーポレイテッド Cardioprotective phosphonates and malonates
JP2003528146A (en) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド Treatment of cerebrovascular disease
CN1095472C (en) 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 Folica acid-polysaccharide composite and its preparation and medical composition with the composite as active component
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
ATE364595T1 (en) 2000-07-07 2007-07-15 Medicure Int Inc PYRIDOXINE AND PYRIDOXAL ANALOGS AS CARDIOVASCULAR THERAPEUTICS
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
WO2022005839A1 (en) 2020-06-30 2022-01-06 L'oreal Natural non-sulfate rinse-off cleansing compositions with high oil loading, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2555463A (en) * 1949-03-28 1951-06-05 Parke Davis & Co Stabilized sodium pantothenate composition
FR1034595A (en) * 1950-09-08 1953-07-27 Improvements for the treatment of mannogalactan hemicelluloses, to obtain a delayed imbibition, suitable for therapeutic purposes

Also Published As

Publication number Publication date
BE733145A (en) 1969-11-17
AT285811B (en) 1970-11-10
BR6908845D0 (en) 1973-02-08
DE1767499A1 (en) 1971-09-09
SE357304B (en) 1973-06-25
GB1201014A (en) 1970-08-05
IL32096A0 (en) 1969-06-25
NL6907431A (en) 1969-11-18
DK122007B (en) 1972-01-03
FR2008690A1 (en) 1970-01-23
CH522405A (en) 1972-05-15

Similar Documents

Publication Publication Date Title
ES367284A1 (en) Storage-stable vitamin preparations
DeVan The concept of neutrocentric occlusion as related to denture stability
IL33499A (en) 1,3,4-thiadiazolyl-(5)-ureas,their preparation and herbicidal compositions containing them
IL30585A0 (en) 1,2,4-thiadiazolyl ureas,their preparation and use as herbicides
BENNETT et al. The effect of environment on the fatigue properties of selected engineering alloys
ES415398A1 (en) Cyanophenoxyacetonitriles
Boston et al. Machining titanium
ES343018A1 (en) Difluorochloromethylaryl ureas, their preparation and use as herbicides
IL30488A (en) Pharmaceutical compositions comprising as an active ingredient p-benzoylphenylacetic acid,o-benzoylphenylacetic acid or salts thereof
USD193170S (en) Extruded bakery product
ES415670A1 (en) Dichlorobenzaldehyde-oxime-carbonates
USD154855S (en) Design for a carving set holder
IL30292A0 (en) N-aryl ureas,their preparation and herbicidal compositions containing them
USD165713S (en) Tx i if
GB1197605A (en) Therapeutic Composition
Als-Nielsen et al. LONG-RANGE ORDER IN BETA BRASS
CA535612A (en) Relatively homogeneous low molecular weight copolymers, their preparation and compositions containing the same
Rose The Phosphate Industry of Maury County, Tennessee
ES348415A1 (en) Synergistic fungicidal composition
AU418935B2 (en) Novel pharmaceutical compositions, and processes for preparing the active ingredient thereof
ק. פ. Children Who Hate
CA849567A (en) Alpha-(2-hydroxy-3,5,6-trichloro)-phenylglycol acid and biocidal compositions
AU694466A (en) Novel pharmaceutical compositions, and processes for preparing the active ingredient thereof
CA536897A (en) Relatively homogeneous low molecular weight copolymers, their preparation and compositions containing the same
AU433088B2 (en) Novel sydnonimine derivatives, the preparation thereof and compositions containing thesame